Advertisement
Advertisement
U.S. Markets open in 5 hrs 46 mins
Advertisement
Advertisement
Advertisement
Advertisement

electroCore, Inc. (ECOR)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
0.3480-0.0169 (-4.63%)
At close: 04:00PM EST
0.3650 +0.02 (+4.89%)
After hours: 05:11PM EST
Advertisement

electroCore, Inc.

200 Forge Way
Suite 205
Rockaway, NJ 07866
United States
973 290 0097
https://www.electrocore.com

Sector(s)Healthcare
IndustryMedical Devices
Full Time Employees52

Key Executives

NameTitlePayExercisedYear Born
Mr. Daniel S. GoldbergerCEO & Director810.67kN/A1959
Mr. Joseph P. ErricoCo-Founder, Principal Investor & Director64.5kN/A1969
Dr. Thomas J. Errico M.D.Founder, Independent Director & Principal Investor52.5kN/A1952
Mr. Brian M. PosnerCFO & Corp. Sec.534.28kN/A1962
Mr. Michael RomaniwExec. VP of Systems & OperationsN/AN/A1957
Ms. Jackie DorskyVP of MarketingN/AN/AN/A
Mr. Iain Strickland Ph.D.Sr. VP of Global Sales & StrategyN/AN/AN/A
Ms. Carrie KochekSr. Director of HRN/AN/AN/A
Dr. Peter S. Staats M.B.A., M.D.Chief Medical OfficerN/AN/A1963
Mr. Eric J. LieblerSr. VP of NeurologyN/AN/A1964
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults. Its lead product is gammaCore Sapphire, a rechargeable and reloadable handheld device for regular or intermittent use over many years. The company was incorporated in 2005 and is headquartered in Rockaway, New Jersey.

Corporate Governance

electroCore, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Advertisement
Advertisement